Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
01:21pm, Monday, 27'th Apr 2026
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
29-Year-Old Investor's Goal: Generate ‘$1 Per Minute' In Free Cash Flow
12:01pm, Monday, 27'th Apr 2026
On a recent episode of Thoughtful Money with Adam Taggart, 29-year-old investor Peter Slegers described how he tracks his 18-company portfolio.
J&J sees AI halving the time to generate drug development leads
11:03am, Monday, 27'th Apr 2026
Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for developing drugs, the company's chief information officer said on Monday.
Priority Review is granted to medicines that may offer significant improvements in safety or effectiveness for serious conditions like warm autoimmune hemolytic anemia, a life-threatening disease in w
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
05:50am, Monday, 27'th Apr 2026
This pharma stock is cheap for a reason.
B. Metzler seel. Sohn & Co. AG Purchases 45,458 Shares of Johnson & Johnson $JNJ
03:46am, Monday, 27'th Apr 2026
B. Metzler seel. Sohn and Co. AG grew its position in shares of Johnson and Johnson (NYSE: JNJ) by 10.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities
Gentry Private Wealth LLC Acquires Shares of 2,284 Johnson & Johnson $JNJ
04:00am, Sunday, 26'th Apr 2026
Gentry Private Wealth LLC acquired a new stake in Johnson and Johnson (NYSE: JNJ) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Co
Johnson & Johnson $JNJ Shares Purchased by Evergreen Capital Management LLC
04:01am, Saturday, 25'th Apr 2026
Evergreen Capital Management LLC increased its stake in Johnson and Johnson (NYSE: JNJ) by 13.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports
04:30pm, Friday, 24'th Apr 2026
Johnson & Johnson will start marketing four of its medications on the Trump administration's TrumpRx website on Friday, CBS News reported on Friday.
The FDVV ETF Delivers Higher 5-Year Growth Than the HDV ETF
11:21am, Friday, 24'th Apr 2026
Sector exposure and risk profiles set these two high-yield ETFs apart, shaping their appeal for income and growth-focused investors.
A $900,000 Stock Portfolio Exposed to Just Three Sectors Is a Retirement Time Bomb
07:03am, Friday, 24'th Apr 2026
At 63, with $900,000 in a brokerage account split across tech (45%), healthcare (30%), and financials (25%), you have built something real. The five holdings - Apple (NASDAQ: AAPL), Microsoft (NASDAQ:
Belpointe Asset Management LLC Lowers Stock Holdings in Johnson & Johnson $JNJ
06:28am, Friday, 24'th Apr 2026
Belpointe Asset Management LLC cut its holdings in Johnson and Johnson (NYSE: JNJ) by 24.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (
Benchmark Financial LLC Makes New Investment in Johnson & Johnson $JNJ
05:14am, Friday, 24'th Apr 2026
Benchmark Financial LLC acquired a new position in shares of Johnson and Johnson (NYSE: JNJ) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securiti
Focused Investors LLC Decreases Holdings in Johnson & Johnson $JNJ
03:58am, Friday, 24'th Apr 2026
Focused Investors LLC reduced its holdings in Johnson and Johnson (NYSE: JNJ) by 2.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. Th
Fortis Capital Advisors LLC Has $459,000 Stock Position in Johnson & Johnson $JNJ
03:58am, Friday, 24'th Apr 2026
Fortis Capital Advisors LLC decreased its stake in Johnson and Johnson (NYSE: JNJ) by 60.4% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securitie
